Akihiro Ohba
4PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.Akihiro Ohba, Masato Ozaka, Junki Mizusawa
|Aug 05, 2024
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto
|May 05, 2022
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.Akihiro Ohba, Chigusa Morizane, Makoto Ueno
|Sep 28, 2021
The Role of EUS and EUS-FNA in Differentiating Benign and Malignant Gallbladder Lesions.Susumu Hijioka, Yoshikuni Nagashio, Akihiro Ohba
Pageof 1
Frequent Collaborators
3 joint publications
Naohiro Okano
2 joint publications
Yasuyuki Kawamoto
2 joint publications
Makoto Ueno
2 joint publications
Satoshi Kobayashi
2 joint publications
Masafumi Ikeda
2 joint publications
Junji Furuse
2 joint publications
Takuji Okusaka
1 joint publications
Susumu Hijioka
1 joint publications
Chigusa Morizane
1 joint publications
Yoshito Komatsu
